Aethlon Medical, Inc (AEMD) is a leading medical devices business based in the US. Aethlon Medical is listed on the NASDAQ and employs 8 staff. All prices are listed in US Dollars.
|52-week range||$1.19 - $4.34|
|50-day moving average||$2.2564|
|200-day moving average||$1.7717|
|Wall St. target price||$7|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.386|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Aethlon Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aethlon Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aethlon Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Aethlon Medical shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Gross profit TTM||$650,187|
|Return on assets TTM||-44.71%|
|Return on equity TTM||-85.21%|
|Market capitalisation||$31.9 million|
TTM: trailing 12 months
There are currently 576,211 Aethlon Medical shares held short by investors – that's known as Aethlon Medical's "short interest". This figure is 25.9% up from 457,597 last month.
There are a few different ways that this level of interest in shorting Aethlon Medical shares can be evaluated.
Aethlon Medical's "short interest ratio" (SIR) is the quantity of Aethlon Medical shares currently shorted divided by the average quantity of Aethlon Medical shares traded daily (recently around 4.8 million). Aethlon Medical's SIR currently stands at 0.12. In other words for every 100,000 Aethlon Medical shares traded daily on the market, roughly 120 shares are currently held short.
However Aethlon Medical's short interest can also be evaluated against the total number of Aethlon Medical shares, or, against the total number of tradable Aethlon Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aethlon Medical's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Aethlon Medical shares in existence, roughly 50 shares are currently held short) or 0.05% of the tradable shares (for every 100,000 tradable Aethlon Medical shares, roughly 50 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aethlon Medical.
Find out more about how you can short Aethlon Medical stock.
We're not expecting Aethlon Medical to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Aethlon Medical's shares were split on a 1:15 basis on 15 October 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aethlon Medical shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Aethlon Medical shares which in turn could have impacted Aethlon Medical's share price.
Over the last 12 months, Aethlon Medical's shares have ranged in value from as little as $1.19 up to $4.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aethlon Medical's is 0.678. This would suggest that Aethlon Medical's shares are less volatile than average (for this exchange).
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.